We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
LGI Homes
LGIH
$1.37B
| $570K | ﹤0.01% |
6,365
-900
| -12% | -$86.9K |
|
1102
First Bancorp
FBP
$4.49B
| $569K | ﹤0.01% |
31,131
-5,400
| -15% | -$94.5K |
|
|
ACLX
1103
DELISTED
Arcellx
ACLX
| $568K | ﹤0.01% |
+10,300
| New | +$560K |
|
1104
NMI Holdings
NMIH
$3.42B
| $568K | ﹤0.01% |
16,700
| – | – |
|
1105
Werner Enterprises
WERN
$2.31B
| $567K | ﹤0.01% |
15,830
+7,500
| +90% | +$274K |
|
1106
Wendy's
WEN
$1.65B
| $567K | ﹤0.01% |
33,457
+2,700
| +9% | +$49.1K |
|
1107
Fortrea Holdings
FTRE
$1.69B
| $562K | ﹤0.01% |
24,100
+4,700
| +24% | +$146K |
|
1108
Dyne Therapeutics
DYN
$4.85B
| $561K | ﹤0.01% |
+15,900
| New | +$462K |
|
1109
Integra LifeSciences
IART
$1.42B
| $560K | ﹤0.01% |
19,202
+6,900
| +56% | +$205K |
|
|
CVSA
1110
Covista Inc
CVSA
$4.49B
| $559K | ﹤0.01% |
8,195
| – | – |
|
|
HI
1111
DELISTED
Hillenbrand
HI
| $556K | ﹤0.01% |
13,897
| – | – |
|
1112
Graham Holdings Company
GHC
$4.97B
| $555K | ﹤0.01% |
793
-100
| -11% | -$73.1K |
|
1113
Walker & Dunlop
WD
$1.47B
| $555K | ﹤0.01% |
5,651
| – | – |
|
1114
Nomad Foods
NOMD
$1.68B
| $554K | ﹤0.01% |
33,600
| – | – |
|
1115
A.O. Smith
AOS
$8.49B
| $553K | ﹤0.01% |
6,757
| – | – |
|
1116
Minerals Technologies
MTX
$2.26B
| $552K | ﹤0.01% |
6,637
| – | – |
|
1117
Urban Outfitters
URBN
$6.53B
| $552K | ﹤0.01% |
13,453
| – | – |
|
|
ENV
1118
DELISTED
ENVESTNET, INC.
ENV
| $552K | ﹤0.01% |
8,823
-12,300
| -58% | -$774K |
|
|
ROIC
1119
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $549K | ﹤0.01% |
44,197
+17,200
| +64% | +$213K |
|
1120
Clarivate
CLVT
$1.25B
| $547K | ﹤0.01% |
96,200
-15,000
| -13% | -$95.7K |
|
1121
Cathay General Bancorp
CATY
$4.31B
| $546K | ﹤0.01% |
14,488
+2,500
| +21% | +$90.7K |
|
1122
Fulton Financial
FULT
$4.69B
| $544K | ﹤0.01% |
32,013
-2,800
| -8% | -$45.4K |
|
1123
Stride
LRN
$3.48B
| $543K | ﹤0.01% |
7,700
| – | – |
|
1124
Hims & Hers Health
HIMS
$6.71B
| $541K | ﹤0.01% |
26,800
| – | – |
|
1125
Knife River
KNF
$3.74B
| $540K | ﹤0.01% |
+7,700
| New | +$575K |
|
Similar funds
GAM
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.